+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)

Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)

Minerva Cardioangiologica 33(5): 251-258

(PDF emailed within 1 workday: $29.90)

Accession: 040728169

Download citation: RISBibTeXText

PMID: 4033966

Related references

Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography. Minerva Cardioangiologica 36(4): 159-165, 1988

Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels. Deutsche Medizinische Wochenschrift 109(13): 492-495, 1984

Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 17. Mexiletine (Mexitil). Sygeplejersken 81(4): 25-25, 1981

Value of holter monitoring in predicting arrhythmia recurrence on amiodarone. American Heart Association Monograph (107): II-437, 1984

Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone. Nihon Rinsho. Japanese Journal of Clinical Medicine 43(11): 2428-2434, 1985

Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. American Journal of Cardiology 55(6): 709-712, 1985

Clinical study evaluated by Holter monitoring and by mexiletine serum levels in ventricular arrhythmias. Giornale Italiano di Cardiologia 12(2): 115-121, 1982

Practical application of Holter ECG monitoring. Part I. Basic principles of the equipment of Holter ECG monitoring system. Indications for Holter monitoring. Kardiologiia 42(5): 85-91, 2002

Mexitil, a new anti-arrhythmia agent. Medizinische Klinik 75(6): 235-237, 1980

The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents. Archives des Maladies du Coeur et des Vaisseaux 84 Spec No 2: 21-25, 1991

Clinical study of the anti-arrhythmia preparation, mexitil. Kardiologiia 20(10): 100-102, 1980

Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients. Journal of Clinical Pharmacology 42(3): 342-346, 2002

Determination of plasma levels of cardiovascular anti-arrhythmia drugs. Technical aspects and clinical prospectives. La Clinica Terapeutica 120(6): 529-537, 1987

Holter monitoring in dogs: comparison between a computerized system and visual arrhythmia analyses. Berliner und Munchener Tierarztliche Wochenschrift 112(6/7): 239-242, 1999

Clinical characteristics of ventricular arrhythmia in NIDDM: Evaluation of arrhythmia using Holter ECG monitoring. Journal of the Japan Diabetes Society 37(5): 349-355, 1994